Augmentation in Tx-resistant OCD: an Open Label Trial

Completed

Conditions studied: Obsessive Compulsive Disorder

In brief

This study examines the use of Acamprosate (Campral(R)) in the treatment of Obsessive Compulsive Disorder (OCD). The treatment of this condition is difficulty and a large percentage of patients fail to respond to medications and have residual symptoms. Such patients are referred to as having treatment resistant OCD.

Key facts

Study ID
NCT00590642
Run by
Creighton University
People needed
30
Starts
2006-04-01
Expected to finish
2009-10-01
Last updated by the study team
2009-12-01

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.